speb/financial-data huggingface dataset:
LALPATHLAB.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 914000000.00
LALPATHLAB.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -72000000.00
LALPATHLAB.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -72000000.00
LALPATHLAB.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 2037000000.00
LALPATHLAB.NS income_statement (quarterly, 2025-12-31) — Normalized Income: 1126330651.65
LALPATHLAB.NS income_statement (quarterly, 2025-12-31) — Operating Income: 1372000000.00
LALPATHLAB.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 6598000000.00
LALPATHLAB.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 244000000.00
LALPATHLAB.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 1215000000.00
LALPATHLAB.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
LALPATHLAB.NS income_statement (quarterly, 2025-12-31) — Pretax Income: 1243000000.00
LALPATHLAB.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 2245000000.00
LALPATHLAB.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 421000000.00
LALPATHLAB.NS income_statement (quarterly, 2025-12-31) — Special Income Charges: -301000000.00
LALPATHLAB.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -79669348.35
LALPATHLAB.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 329000000.00
LALPATHLAB.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.26
LALPATHLAB.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 5226000000.00
LALPATHLAB.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items: -301000000.00
LALPATHLAB.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -301000000.00
LALPATHLAB.NS income_statement (annual, 2026-03-31) — +Operating Expense: 12031910000.00
LALPATHLAB.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 3247000000.00
LALPATHLAB.NS income_statement (annual, 2026-03-31) — +Total Revenue: 27627650000.00
LALPATHLAB.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 7027000000.00
LALPATHLAB.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 1805970000.00
LALPATHLAB.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 1805970000.00
LALPATHLAB.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 1106920000.00
LALPATHLAB.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 1106920000.00
LALPATHLAB.NS balance_sheet (annual, 2026-03-31) — Accumulated Depreciation: -6125640000.00
LALPATHLAB.NS balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -6125640000.00
LALPATHLAB.NS balance_sheet (annual, 2026-03-31) — Additional Paid In Capital: 837590000.00
LALPATHLAB.NS balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 837590000.00
LALPATHLAB.NS balance_sheet (annual, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -306850000.00
LALPATHLAB.NS balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -306850000.00
LALPATHLAB.NS income_statement (annual, 2026-03-31) — Amortization: 648160000.00
LALPATHLAB.NS cash_flow (annual, 2026-03-31) — Amortization Cash Flow: 648160000.00
LALPATHLAB.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 1956770000.00
LALPATHLAB.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 1956770000.00
LALPATHLAB.NS income_statement (annual, 2026-03-31) — Basic Average Shares: 166913882.00
LALPATHLAB.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 167048346.00
LALPATHLAB.NS income_statement (annual, 2026-03-31) — Basic EPS: 30.24
LALPATHLAB.NS income_statement (quarterly, 2026-03-31) — Basic EPS: 7.86
LALPATHLAB.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 2926260000.00
LALPATHLAB.NS balance_sheet (annual, 2026-03-31) — Buildings And Improvements: 6403620000.00
LALPATHLAB.NS balance_sheet (quarterly, 2026-03-31) — Buildings And Improvements: 6403620000.00
LALPATHLAB.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -1733830000.00
LALPATHLAB.NS balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 1989940000.00
LALPATHLAB.NS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 1989940000.00
LALPATHLAB.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 1675550000.00
LALPATHLAB.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 1675550000.00
LALPATHLAB.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 2427980000.00
LALPATHLAB.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 2427980000.00
LALPATHLAB.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 13307490000.00
LALPATHLAB.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 13307490000.00
LALPATHLAB.NS cash_flow (annual, 2026-03-31) — Cash Dividends Paid: -2226150000.00
LALPATHLAB.NS balance_sheet (annual, 2026-03-31) — Cash Equivalents: 2179490000.00
LALPATHLAB.NS balance_sheet (quarterly, 2026-03-31) — Cash Equivalents: 2179490000.00
LALPATHLAB.NS balance_sheet (annual, 2026-03-31) — Cash Financial: 248490000.00
LALPATHLAB.NS balance_sheet (quarterly, 2026-03-31) — Cash Financial: 248490000.00
LALPATHLAB.NS cash_flow (annual, 2026-03-31) — Change In Inventory: -77230000.00
LALPATHLAB.NS cash_flow (annual, 2026-03-31) — Change In Other Current Assets: -21000000.00
LALPATHLAB.NS cash_flow (annual, 2026-03-31) — Change In Other Current Liabilities: 45000000.00
LALPATHLAB.NS cash_flow (annual, 2026-03-31) — Change In Payable: 135470000.00
LALPATHLAB.NS cash_flow (annual, 2026-03-31) — Change In Receivables: -276070000.00
LALPATHLAB.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: 266210000.00
LALPATHLAB.NS cash_flow (annual, 2026-03-31) — Changes In Cash: -498280000.00
LALPATHLAB.NS balance_sheet (annual, 2026-03-31) — Common Stock: 1675550000.00
LALPATHLAB.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 1675550000.00
LALPATHLAB.NS cash_flow (annual, 2026-03-31) — Common Stock Dividend Paid: -2226150000.00
LALPATHLAB.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 25081390000.00
LALPATHLAB.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 25081390000.00
LALPATHLAB.NS cash_flow (annual, 2026-03-31) — Common Stock Issuance: 185980000.00
LALPATHLAB.NS balance_sheet (annual, 2026-03-31) — Construction In Progress: 59490000.00
LALPATHLAB.NS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 59490000.00
LALPATHLAB.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 5346220000.00
LALPATHLAB.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 1352000000.00
LALPATHLAB.NS balance_sheet (annual, 2026-03-31) — Current Assets: 15664920000.00
LALPATHLAB.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 15664920000.00
LALPATHLAB.NS balance_sheet (annual, 2026-03-31) — Current Capital Lease Obligation: 535740000.00
LALPATHLAB.NS balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 535740000.00
LALPATHLAB.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 535740000.00
LALPATHLAB.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 535740000.00
LALPATHLAB.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 4506170000.00
LALPATHLAB.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 4506170000.00
LALPATHLAB.NS cash_flow (annual, 2026-03-31) — Deferred Tax: 1593310000.00
LALPATHLAB.NS cash_flow (annual, 2026-03-31) — Depreciation: 969870000.00
LALPATHLAB.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 1618030000.00
LALPATHLAB.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 1618030000.00
LALPATHLAB.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 446000000.00
LALPATHLAB.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 969870000.00
LALPATHLAB.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 446000000.00
LALPATHLAB.NS income_statement (annual, 2026-03-31) — Diluted Average Shares: 167151719.00
LALPATHLAB.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 167261146.00
LALPATHLAB.NS income_statement (annual, 2026-03-31) — Diluted EPS: 30.20
LALPATHLAB.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: 7.85
LALPATHLAB.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 5047790000.00
LALPATHLAB.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 1313000000.00
LALPATHLAB.NS income_statement (annual, 2026-03-31) — EBIT: 6918850000.00
LALPATHLAB.NS income_statement (quarterly, 2026-03-31) — EBIT: 1662000000.00
LALPATHLAB.NS income_statement (annual, 2026-03-31) — EBITDA: 8536880000.00
LALPATHLAB.NS income_statement (quarterly, 2026-03-31) — EBITDA: 2108000000.00
LALPATHLAB.NS cash_flow (annual, 2026-03-31) — End Cash Position: 2427980000.00
LALPATHLAB.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: -2635720000.00
LALPATHLAB.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: 4622250000.00
LALPATHLAB.NS cash_flow (annual, 2026-03-31) — Gain Loss On Investment Securities: -277010000.00
LALPATHLAB.NS cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of PPE: 9150000.00
LALPATHLAB.NS income_statement (annual, 2026-03-31) — General And Administrative Expense: 1843220000.00
LALPATHLAB.NS balance_sheet (annual, 2026-03-31) — Goodwill: 5481930000.00
LALPATHLAB.NS balance_sheet (quarterly, 2026-03-31) — Goodwill: 5481930000.00
LALPATHLAB.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 7407880000.00
LALPATHLAB.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 7407880000.00
LALPATHLAB.NS balance_sheet (annual, 2026-03-31) — Gross Accounts Receivable: 1413770000.00
LALPATHLAB.NS balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 1413770000.00
LALPATHLAB.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 11023790000.00
LALPATHLAB.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 11023790000.00
LALPATHLAB.NS income_statement (annual, 2026-03-31) — Gross Profit: 22281430000.00
LALPATHLAB.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 5675000000.00
LALPATHLAB.NS income_statement (annual, 2026-03-31) — Interest Expense: 228000000.00
LALPATHLAB.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 61000000.00
LALPATHLAB.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 228000000.00
LALPATHLAB.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 61000000.00
LALPATHLAB.NS income_statement (annual, 2026-03-31) — Interest Income: 670120000.00
LALPATHLAB.NS income_statement (annual, 2026-03-31) — Interest Income Non Operating: 670120000.00
LALPATHLAB.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -228000000.00
LALPATHLAB.NS cash_flow (annual, 2026-03-31) — Interest Received Cfi: 663900000.00
LALPATHLAB.NS balance_sheet (annual, 2026-03-31) — Inventory: 438550000.00
LALPATHLAB.NS balance_sheet (quarterly, 2026-03-31) — Inventory: 438550000.00
LALPATHLAB.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 25081390000.00
LALPATHLAB.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 25081390000.00
LALPATHLAB.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: -4218640000.00
LALPATHLAB.NS balance_sheet (annual, 2026-03-31) — Investment Properties: 327850000.00
LALPATHLAB.NS balance_sheet (quarterly, 2026-03-31) — Investment Properties: 327850000.00
LALPATHLAB.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 1956770000.00
LALPATHLAB.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 1956770000.00
LALPATHLAB.NS cash_flow (annual, 2026-03-31) — Issuance Of Capital Stock: 185980000.00
LALPATHLAB.NS balance_sheet (annual, 2026-03-31) — Land And Improvements: 269830000.00
LALPATHLAB.NS balance_sheet (quarterly, 2026-03-31) — Land And Improvements: 269830000.00
LALPATHLAB.NS balance_sheet (annual, 2026-03-31) — Long Term Capital Lease Obligation: 1454200000.00
LALPATHLAB.NS balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 1454200000.00
LALPATHLAB.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 1454200000.00
LALPATHLAB.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 1454200000.00
LALPATHLAB.NS cash_flow (annual, 2026-03-31) — Long Term Debt Payments: 0.00
LALPATHLAB.NS balance_sheet (annual, 2026-03-31) — Machinery Furniture Equipment: 4290850000.00
LALPATHLAB.NS balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 4290850000.00
LALPATHLAB.NS balance_sheet (annual, 2026-03-31) — Minority Interest: 331440000.00
LALPATHLAB.NS balance_sheet (quarterly, 2026-03-31) — Minority Interest: 331440000.00
LALPATHLAB.NS income_statement (annual, 2026-03-31) — Minority Interests: -49750000.00
LALPATHLAB.NS income_statement (quarterly, 2026-03-31) — Minority Interests: -9000000.00
LALPATHLAB.NS cash_flow (annual, 2026-03-31) — Net Common Stock Issuance: 185980000.00
LALPATHLAB.NS cash_flow (annual, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: 2280000.00
LALPATHLAB.NS income_statement (annual, 2026-03-31) — Net Income: 5047790000.00
LALPATHLAB.NS income_statement (quarterly, 2026-03-31) — Net Income: 1313000000.00
LALPATHLAB.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 5047790000.00
LALPATHLAB.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 1313000000.00
LALPATHLAB.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 5097540000.00
LALPATHLAB.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 1322000000.00
LALPATHLAB.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 5047790000.00
LALPATHLAB.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 1313000000.00
LALPATHLAB.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 5047790000.00
LALPATHLAB.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 1313000000.00
LALPATHLAB.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 5097540000.00
LALPATHLAB.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 5097540000.00
LALPATHLAB.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 1322000000.00
LALPATHLAB.NS cash_flow (annual, 2026-03-31) — Net Intangibles Purchase And Sale: -63630000.00
LALPATHLAB.NS income_statement (annual, 2026-03-31) — Net Interest Income: 442120000.00
LALPATHLAB.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -61000000.00
LALPATHLAB.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: -3188320000.00
LALPATHLAB.NS cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: 0.00
LALPATHLAB.NS cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: 0.00
LALPATHLAB.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: 442120000.00
LALPATHLAB.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -61000000.00
LALPATHLAB.NS cash_flow (annual, 2026-03-31) — Net Other Investing Changes: 34210000.00
LALPATHLAB.NS balance_sheet (annual, 2026-03-31) — Net PPE: 4898150000.00
LALPATHLAB.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 4898150000.00
LALPATHLAB.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -1664800000.00
LALPATHLAB.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 17673510000.00
LALPATHLAB.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 17673510000.00
LALPATHLAB.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Assets: 875380000.00
LALPATHLAB.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 875380000.00
LALPATHLAB.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Liabilities: 60280000.00
LALPATHLAB.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 60280000.00
LALPATHLAB.NS balance_sheet (annual, 2026-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 26480000.00
LALPATHLAB.NS balance_sheet (quarterly, 2026-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 26480000.00
LALPATHLAB.NS balance_sheet (annual, 2026-03-31) — Non Current Prepaid Assets: 137790000.00
LALPATHLAB.NS balance_sheet (quarterly, 2026-03-31) — Non Current Prepaid Assets: 137790000.00
LALPATHLAB.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 8568330000.00
LALPATHLAB.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 2108000000.00
LALPATHLAB.NS income_statement (annual, 2026-03-31) — Normalized Income: 5071750727.41
LALPATHLAB.NS income_statement (quarterly, 2026-03-31) — Normalized Income: 1313000000.00
LALPATHLAB.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: 6356080000.00
LALPATHLAB.NS income_statement (annual, 2026-03-31) — Operating Income: 10249520000.00
LALPATHLAB.NS income_statement (quarterly, 2026-03-31) — Operating Income: 2428000000.00
LALPATHLAB.NS income_statement (annual, 2026-03-31) — Operating Revenue: 27627650000.00
LALPATHLAB.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 7027000000.00
LALPATHLAB.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 166977774.00
LALPATHLAB.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 166977774.00
LALPATHLAB.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: 660540000.00
LALPATHLAB.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 660540000.00
LALPATHLAB.NS balance_sheet (annual, 2026-03-31) — Other Intangible Assets: 1925950000.00
LALPATHLAB.NS balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 1925950000.00
LALPATHLAB.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: -479750000.00
LALPATHLAB.NS balance_sheet (annual, 2026-03-31) — Other Non Current Assets: -400000.00
LALPATHLAB.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: -400000.00
LALPATHLAB.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: -3969340000.00
LALPATHLAB.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: -766000000.00
LALPATHLAB.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 2303510000.00
LALPATHLAB.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 1513000000.00
LALPATHLAB.NS balance_sheet (annual, 2026-03-31) — Other Payable: 517930000.00
LALPATHLAB.NS balance_sheet (quarterly, 2026-03-31) — Other Payable: 517930000.00
LALPATHLAB.NS balance_sheet (annual, 2026-03-31) — Other Receivables: 370190000.00
LALPATHLAB.NS balance_sheet (quarterly, 2026-03-31) — Other Receivables: 370190000.00
LALPATHLAB.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 10879510000.00
LALPATHLAB.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 10879510000.00
LALPATHLAB.NS income_statement (annual, 2026-03-31) — Other Special Charges: 306670000.00
LALPATHLAB.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
LALPATHLAB.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
LALPATHLAB.NS balance_sheet (annual, 2026-03-31) — Payables: 2394680000.00
LALPATHLAB.NS balance_sheet (quarterly, 2026-03-31) — Payables: 2394680000.00
LALPATHLAB.NS balance_sheet (annual, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 737710000.00
LALPATHLAB.NS balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 737710000.00
LALPATHLAB.NS balance_sheet (annual, 2026-03-31) — Prepaid Assets: 428030000.00
LALPATHLAB.NS balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 428030000.00
LALPATHLAB.NS income_statement (annual, 2026-03-31) — Pretax Income: 6690850000.00
LALPATHLAB.NS income_statement (quarterly, 2026-03-31) — Pretax Income: 1601000000.00
LALPATHLAB.NS balance_sheet (annual, 2026-03-31) — Properties: 0.00
LALPATHLAB.NS balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
LALPATHLAB.NS cash_flow (annual, 2026-03-31) — Provisionand Write Offof Assets: 40600000.00
LALPATHLAB.NS cash_flow (annual, 2026-03-31) — Purchase Of Intangibles: -63630000.00
LALPATHLAB.NS cash_flow (annual, 2026-03-31) — Purchase Of Investment: -15156370000.00
LALPATHLAB.NS cash_flow (annual, 2026-03-31) — Purchase Of PPE: -1670200000.00
LALPATHLAB.NS balance_sheet (annual, 2026-03-31) — Raw Materials: 438550000.00
LALPATHLAB.NS balance_sheet (quarterly, 2026-03-31) — Raw Materials: 438550000.00
LALPATHLAB.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 5346220000.00
LALPATHLAB.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 1352000000.00
LALPATHLAB.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 1618030000.00
LALPATHLAB.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 446000000.00
LALPATHLAB.NS income_statement (annual, 2026-03-31) — Rent And Landing Fees: 325690000.00
LALPATHLAB.NS income_statement (annual, 2026-03-31) — Rent Expense Supplemental: 325690000.00
LALPATHLAB.NS cash_flow (annual, 2026-03-31) — Repayment Of Debt: 0.00
LALPATHLAB.NS balance_sheet (annual, 2026-03-31) — Restricted Cash: 13740000.00
LALPATHLAB.NS balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 13740000.00
LALPATHLAB.NS balance_sheet (annual, 2026-03-31) — Retained Earnings: 21527340000.00
LALPATHLAB.NS balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 21527340000.00
LALPATHLAB.NS cash_flow (annual, 2026-03-31) — Sale Of Investment: 11968050000.00
LALPATHLAB.NS cash_flow (annual, 2026-03-31) — Sale Of PPE: 5400000.00
LALPATHLAB.NS income_statement (annual, 2026-03-31) — Selling And Marketing Expense: 910290000.00
LALPATHLAB.NS income_statement (annual, 2026-03-31) — Selling General And Administration: 2753510000.00
LALPATHLAB.NS balance_sheet (annual, 2026-03-31) — Share Issued: 167555020.00
LALPATHLAB.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 167555020.00
LALPATHLAB.NS income_statement (annual, 2026-03-31) — Special Income Charges: -308460000.00
LALPATHLAB.NS income_statement (quarterly, 2026-03-31) — Special Income Charges: 0.00
LALPATHLAB.NS cash_flow (annual, 2026-03-31) — Stock Based Compensation: 237760000.00
LALPATHLAB.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 25081390000.00
LALPATHLAB.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 25081390000.00
LALPATHLAB.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 17673510000.00
LALPATHLAB.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 17673510000.00
LALPATHLAB.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: -7489272.59
LALPATHLAB.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
LALPATHLAB.NS income_statement (annual, 2026-03-31) — Tax Provision: 1593310000.00
LALPATHLAB.NS income_statement (quarterly, 2026-03-31) — Tax Provision: 279000000.00
LALPATHLAB.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.24
LALPATHLAB.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.17
LALPATHLAB.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: -1753830000.00
LALPATHLAB.NS balance_sheet (annual, 2026-03-31) — Total Assets: 31459960000.00
LALPATHLAB.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 31459960000.00
LALPATHLAB.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 25081390000.00
LALPATHLAB.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 25081390000.00
LALPATHLAB.NS balance_sheet (annual, 2026-03-31) — Total Debt: 1989940000.00
LALPATHLAB.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 1989940000.00
LALPATHLAB.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 25412830000.00
LALPATHLAB.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 25412830000.00
LALPATHLAB.NS income_statement (annual, 2026-03-31) — Total Expenses: 17378130000.00
LALPATHLAB.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 4599000000.00
LALPATHLAB.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 6047130000.00
LALPATHLAB.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 6047130000.00
LALPATHLAB.NS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 15795040000.00
LALPATHLAB.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 15795040000.00
LALPATHLAB.NS balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 1540960000.00
LALPATHLAB.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 1540960000.00
LALPATHLAB.NS balance_sheet (annual, 2026-03-31) — Total Tax Payable: 70780000.00
LALPATHLAB.NS balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 70780000.00
LALPATHLAB.NS income_statement (annual, 2026-03-31) — Total Unusual Items: -31450000.00
LALPATHLAB.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items: 0.00
LALPATHLAB.NS income_statement (annual, 2026-03-31) — Total Unusual Items Excluding Goodwill: -31450000.00
LALPATHLAB.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 0.00
LALPATHLAB.NS balance_sheet (annual, 2026-03-31) — Treasury Shares Number: 577246.00
LALPATHLAB.NS balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 577246.00
LALPATHLAB.NS balance_sheet (annual, 2026-03-31) — Treasury Stock: 420350000.00
LALPATHLAB.NS balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 420350000.00
LALPATHLAB.NS balance_sheet (annual, 2026-03-31) — Working Capital: 11158750000.00
LALPATHLAB.NS balance_sheet (quarterly, 2026-03-31) — Working Capital: 11158750000.00
LALPATHLAB.NS income_statement (annual, 2026-03-31) — Write Off: 1790000.00
LALPATHLAB.NS income_statement (quarterly, 2026-06-30) — +Operating Expense: 3271000000.00
LALPATHLAB.NS income_statement (quarterly, 2026-06-30) — +Total Revenue: 7977000000.00
LALPATHLAB.NS income_statement (quarterly, 2026-06-30) — Basic Average Shares: 166995074.00
LALPATHLAB.NS income_statement (quarterly, 2026-06-30) — Basic EPS: 10.15
LALPATHLAB.NS income_statement (quarterly, 2026-06-30) — Cost Of Revenue: 2675000000.00
LALPATHLAB.NS income_statement (quarterly, 2026-06-30) — Depreciation And Amortization In Income Statement: 444000000.00
LALPATHLAB.NS income_statement (quarterly, 2026-06-30) — Depreciation Income Statement: 444000000.00
LALPATHLAB.NS income_statement (quarterly, 2026-06-30) — Diluted Average Shares: 167324778.00
LALPATHLAB.NS income_statement (quarterly, 2026-06-30) — Diluted EPS: 10.13
LALPATHLAB.NS income_statement (quarterly, 2026-06-30) — Diluted NI Availto Com Stockholders: 1695000000.00
LALPATHLAB.NS income_statement (quarterly, 2026-06-30) — EBIT: 2350000000.00
LALPATHLAB.NS income_statement (quarterly, 2026-06-30) — EBITDA: 2794000000.00
LALPATHLAB.NS income_statement (quarterly, 2026-06-30) — Gross Profit: 5302000000.00
LALPATHLAB.NS income_statement (quarterly, 2026-06-30) — Interest Expense: 63000000.00
LALPATHLAB.NS income_statement (quarterly, 2026-06-30) — Interest Expense Non Operating: 63000000.00
LALPATHLAB.NS income_statement (quarterly, 2026-06-30) — Minority Interests: -10000000.00
LALPATHLAB.NS income_statement (quarterly, 2026-06-30) — Net Income: 1695000000.00
LALPATHLAB.NS income_statement (quarterly, 2026-06-30) — Net Income Common Stockholders: 1695000000.00
LALPATHLAB.NS income_statement (quarterly, 2026-06-30) — Net Income Continuous Operations: 1705000000.00
LALPATHLAB.NS income_statement (quarterly, 2026-06-30) — Net Income From Continuing And Discontinued Operation: 1695000000.00
LALPATHLAB.NS income_statement (quarterly, 2026-06-30) — Net Income From Continuing Operation Net Minority Interest: 1695000000.00
LALPATHLAB.NS income_statement (quarterly, 2026-06-30) — Net Income Including Noncontrolling Interests: 1705000000.00
LALPATHLAB.NS income_statement (quarterly, 2026-06-30) — Net Interest Income: -63000000.00
LALPATHLAB.NS income_statement (quarterly, 2026-06-30) — Net Non Operating Interest Income Expense: -63000000.00
LALPATHLAB.NS income_statement (quarterly, 2026-06-30) — Normalized EBITDA: 2794000000.00
LALPATHLAB.NS income_statement (quarterly, 2026-06-30) — Normalized Income: 1695000000.00
LALPATHLAB.NS income_statement (quarterly, 2026-06-30) — Operating Income: 2031000000.00
LALPATHLAB.NS income_statement (quarterly, 2026-06-30) — Operating Revenue: 7977000000.00
LALPATHLAB.NS income_statement (quarterly, 2026-06-30) — Other Non Operating Income Expenses: 319000000.00
LALPATHLAB.NS income_statement (quarterly, 2026-06-30) — Other Operating Expenses: 1500000000.00
LALPATHLAB.NS income_statement (quarterly, 2026-06-30) — Otherunder Preferred Stock Dividend: 0.00
LALPATHLAB.NS income_statement (quarterly, 2026-06-30) — Pretax Income: 2287000000.00
LALPATHLAB.NS income_statement (quarterly, 2026-06-30) — Reconciled Cost Of Revenue: 2675000000.00
LALPATHLAB.NS income_statement (quarterly, 2026-06-30) — Reconciled Depreciation: 444000000.00
LALPATHLAB.NS income_statement (quarterly, 2026-06-30) — Special Income Charges: 0.00
LALPATHLAB.NS income_statement (quarterly, 2026-06-30) — Tax Effect Of Unusual Items: 0.00
LALPATHLAB.NS income_statement (quarterly, 2026-06-30) — Tax Provision: 582000000.00
LALPATHLAB.NS income_statement (quarterly, 2026-06-30) — Tax Rate For Calcs: 0.25
LALPATHLAB.NS income_statement (quarterly, 2026-06-30) — Total Expenses: 5946000000.00
LALPATHLAB.NS income_statement (quarterly, 2026-06-30) — Total Unusual Items: 0.00
LALPATHLAB.NS income_statement (quarterly, 2026-06-30) — Total Unusual Items Excluding Goodwill: 0.00
LAM.AX balance_sheet (annual, 2021-12-31) — Available For Sale Securities: 548000.00
LAM.AX income_statement (annual, 2021-12-31) — Basic Average Shares: 176455146.00
LAM.AX income_statement (annual, 2021-12-31) — Basic EPS: -0.05
LAM.AX income_statement (annual, 2021-12-31) — Cost Of Revenue: 94688.00
LAM.AX income_statement (annual, 2021-12-31) — Diluted Average Shares: 176455146.00
LAM.AX income_statement (annual, 2021-12-31) — Diluted EPS: -0.05
LAM.AX balance_sheet (annual, 2021-12-31) — Duefrom Related Parties Current: 0.00
LAM.AX income_statement (annual, 2021-12-31) — Gross Profit: -94688.00
LAM.AX balance_sheet (annual, 2021-12-31) — Investmentin Financial Assets: 548000.00
LAM.AX balance_sheet (annual, 2021-12-31) — Investments And Advances: 548000.00
LAM.AX balance_sheet (annual, 2021-12-31) — Long Term Debt: 6244100.00
LAM.AX balance_sheet (annual, 2021-12-31) — Long Term Debt And Capital Lease Obligation: 6244100.00
LAM.AX cash_flow (annual, 2021-12-31) — Net Short Term Debt Issuance: 60000.00
LAM.AX balance_sheet (annual, 2021-12-31) — Other Current Liabilities: 6972497.00
LAM.AX balance_sheet (annual, 2021-12-31) — Other Equity Interest: 1616046.00
LAM.AX income_statement (annual, 2021-12-31) — Reconciled Cost Of Revenue: 94688.00
LAM.AX cash_flow (annual, 2021-12-31) — Short Term Debt Issuance: 60000.00
LAM.AX cash_flow (annual, 2021-12-31) — Short Term Debt Payments: -773475.00
LAM.AX income_statement (annual, 2022-12-31) — +Operating Expense: 2756602.00
LAM.AX income_statement (annual, 2022-12-31) — +Total Revenue: 0.00
LAM.AX balance_sheet (annual, 2022-12-31) — Accounts Payable: 1164165.00
LAM.AX balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -3540988.00
LAM.AX balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 30744714.00
LAM.AX income_statement (annual, 2022-12-31) — Basic Average Shares: 206774607.00
LAM.AX income_statement (annual, 2022-12-31) — Basic EPS: 0.00
LAM.AX cash_flow (annual, 2022-12-31) — Beginning Cash Position: 7639753.00
LAM.AX cash_flow (annual, 2022-12-31) — Capital Expenditure: -5005687.00
LAM.AX balance_sheet (annual, 2022-12-31) — Capital Stock: 168027962.00
LAM.AX balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 1587213.00
LAM.AX balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 5773057.00
LAM.AX balance_sheet (annual, 2022-12-31) — Cash Financial: 1587213.00
LAM.AX cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 3879412.00
LAM.AX cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -8571170.00
LAM.AX cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -1388226.00
LAM.AX cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 962187.00
LAM.AX cash_flow (annual, 2022-12-31) — Change In Receivables: -207175.00
LAM.AX cash_flow (annual, 2022-12-31) — Change In Working Capital: 755012.00
LAM.AX cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -207175.00
LAM.AX cash_flow (annual, 2022-12-31) — Changes In Cash: -6079984.00
LAM.AX balance_sheet (annual, 2022-12-31) — Common Stock: 168027962.00
LAM.AX balance_sheet (annual, 2022-12-31) — Common Stock Equity: 87156662.00
LAM.AX cash_flow (annual, 2022-12-31) — Common Stock Issuance: 0.00
LAM.AX balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 156393.00
LAM.AX balance_sheet (annual, 2022-12-31) — Current Assets: 6264957.00
LAM.AX balance_sheet (annual, 2022-12-31) — Current Debt: 6013543.00
LAM.AX balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 6013543.00
LAM.AX balance_sheet (annual, 2022-12-31) — Current Liabilities: 8898001.00
LAM.AX cash_flow (annual, 2022-12-31) — Deferred Income Tax: 179095.00
LAM.AX cash_flow (annual, 2022-12-31) — Deferred Tax: 179095.00
LAM.AX cash_flow (annual, 2022-12-31) — Depreciation: 94012.00
LAM.AX cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 94012.00
LAM.AX income_statement (annual, 2022-12-31) — Depreciation Amortization Depletion Income Statement: 94012.00
LAM.AX cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 94012.00
LAM.AX income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 94012.00
LAM.AX income_statement (annual, 2022-12-31) — Depreciation Income Statement: 94012.00
LAM.AX income_statement (annual, 2022-12-31) — Diluted Average Shares: 206774607.00
LAM.AX income_statement (annual, 2022-12-31) — Diluted EPS: 0.00
LAM.AX income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -615803.00
LAM.AX income_statement (annual, 2022-12-31) — EBIT: 698495.00
LAM.AX income_statement (annual, 2022-12-31) — EBITDA: 792507.00
LAM.AX cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: 27444.00
LAM.AX cash_flow (annual, 2022-12-31) — End Cash Position: 1587213.00
LAM.AX cash_flow (annual, 2022-12-31) — Financing Cash Flow: 3879412.00
LAM.AX cash_flow (annual, 2022-12-31) — Free Cash Flow: -6393913.00
LAM.AX cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: -3845219.00
LAM.AX income_statement (annual, 2022-12-31) — Gain On Sale Of Security: 3455097.00
LAM.AX balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: 2890668.00
LAM.AX income_statement (annual, 2022-12-31) — General And Administrative Expense: 2662590.00
LAM.AX balance_sheet (annual, 2022-12-31) — Gross PPE: 96676733.00
LAM.AX income_statement (annual, 2022-12-31) — Interest Expense: 1135203.00
LAM.AX income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 1135203.00
LAM.AX balance_sheet (annual, 2022-12-31) — Invested Capital: 93170205.00
LAM.AX cash_flow (annual, 2022-12-31) — Investing Cash Flow: -8571170.00
LAM.AX balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 0.00
LAM.AX balance_sheet (annual, 2022-12-31) — Investments And Advances: 0.00
LAM.AX cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 0.00
LAM.AX cash_flow (annual, 2022-12-31) — Issuance Of Debt: 0.00
LAM.AX cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -583978.00
LAM.AX balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 586838.00
LAM.AX cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 0.00
LAM.AX balance_sheet (annual, 2022-12-31) — Net Debt: 4426330.00
LAM.AX cash_flow (annual, 2022-12-31) — Net Foreign Currency Exchange Gain Loss: 384349.00
LAM.AX income_statement (annual, 2022-12-31) — Net Income: -615803.00
LAM.AX income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -615803.00
LAM.AX income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -615803.00
LAM.AX income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -615803.00
LAM.AX income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -615803.00
LAM.AX cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -615803.00
LAM.AX income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -615803.00
LAM.AX income_statement (annual, 2022-12-31) — Net Interest Income: -1135203.00
LAM.AX cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -3565483.00
LAM.AX cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -583978.00
LAM.AX cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -583978.00
LAM.AX income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -1135203.00
LAM.AX balance_sheet (annual, 2022-12-31) — Net PPE: 93135745.00
LAM.AX cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -5005687.00
LAM.AX cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: 0.00
LAM.AX balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 87156662.00
LAM.AX balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 3841298.00
LAM.AX balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 3841298.00
LAM.AX balance_sheet (annual, 2022-12-31) — Non Current Prepaid Assets: 495259.00
LAM.AX income_statement (annual, 2022-12-31) — Normalized EBITDA: -2662590.00
LAM.AX income_statement (annual, 2022-12-31) — Normalized Income: -3165319.08
LAM.AX cash_flow (annual, 2022-12-31) — Operating Cash Flow: -1388226.00
LAM.AX cash_flow (annual, 2022-12-31) — Operating Gains Losses: -3460870.00
LAM.AX income_statement (annual, 2022-12-31) — Operating Income: -2756602.00
LAM.AX income_statement (annual, 2022-12-31) — Operating Revenue: 0.00
LAM.AX balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 210979696.00
LAM.AX balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 6013543.00
LAM.AX balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 1528727.00
LAM.AX balance_sheet (annual, 2022-12-31) — Other Equity Interest: 688576.00
LAM.AX income_statement (annual, 2022-12-31) — Other Gand A: 1674054.00
LAM.AX income_statement (annual, 2022-12-31) — Other Income Expense: 3455097.00
LAM.AX cash_flow (annual, 2022-12-31) — Other Non Cash Items: 671792.00
LAM.AX balance_sheet (annual, 2022-12-31) — Other Payable: 35173.00
LAM.AX balance_sheet (annual, 2022-12-31) — Other Properties: 96089895.00
LAM.AX balance_sheet (annual, 2022-12-31) — Other Receivables: 80336.00
LAM.AX balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 4185844.00
LAM.AX balance_sheet (annual, 2022-12-31) — Payables: 1199338.00
LAM.AX balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 1355731.00
LAM.AX balance_sheet (annual, 2022-12-31) — Prepaid Assets: 357637.00
LAM.AX income_statement (annual, 2022-12-31) — Pretax Income: -436708.00
LAM.AX cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 4463390.00
LAM.AX cash_flow (annual, 2022-12-31) — Purchase Of Investment: -7092983.00
LAM.AX cash_flow (annual, 2022-12-31) — Purchase Of PPE: -5005687.00
LAM.AX balance_sheet (annual, 2022-12-31) — Receivables: 134263.00
LAM.AX income_statement (annual, 2022-12-31) — Reconciled Depreciation: 94012.00
LAM.AX cash_flow (annual, 2022-12-31) — Repayment Of Debt: -583978.00
LAM.AX balance_sheet (annual, 2022-12-31) — Retained Earnings: -115195258.00
LAM.AX income_statement (annual, 2022-12-31) — Salaries And Wages: 988536.00
LAM.AX cash_flow (annual, 2022-12-31) — Sale Of Investment: 3527500.00
LAM.AX income_statement (annual, 2022-12-31) — Selling General And Administration: 2662590.00
LAM.AX balance_sheet (annual, 2022-12-31) — Share Issued: 210979696.00
LAM.AX cash_flow (annual, 2022-12-31) — Short Term Debt Issuance: 0.00
LAM.AX income_statement (annual, 2022-12-31) — Special Income Charges: 0.00
LAM.AX cash_flow (annual, 2022-12-31) — Stock Based Compensation: 988536.00
LAM.AX balance_sheet (annual, 2022-12-31) — Stockholders Equity: 87156662.00
LAM.AX balance_sheet (annual, 2022-12-31) — Tangible Book Value: 87156662.00
LAM.AX income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 905580.92
LAM.AX income_statement (annual, 2022-12-31) — Tax Provision: 179095.00
LAM.AX income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.26
LAM.AX balance_sheet (annual, 2022-12-31) — Taxes Receivable: 53927.00
LAM.AX balance_sheet (annual, 2022-12-31) — Total Assets: 99895961.00
LAM.AX balance_sheet (annual, 2022-12-31) — Total Capitalization: 87156662.00
LAM.AX balance_sheet (annual, 2022-12-31) — Total Debt: 6013543.00
LAM.AX balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 87156662.00
LAM.AX income_statement (annual, 2022-12-31) — Total Expenses: 2756602.00
LAM.AX balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 12739299.00
LAM.AX balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 93631004.00
LAM.AX balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 3841298.00
LAM.AX income_statement (annual, 2022-12-31) — Total Unusual Items: 3455097.00
LAM.AX income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 3455097.00
LAM.AX balance_sheet (annual, 2022-12-31) — Working Capital: -2633044.00
LAM.AX income_statement (annual, 2023-12-31) — +Operating Expense: 2750678.00
LAM.AX income_statement (annual, 2023-12-31) — +Total Revenue: 0.00
LAM.AX balance_sheet (annual, 2023-12-31) — Accounts Payable: 905448.00
LAM.AX balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -3169012.00
LAM.AX balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 30556905.00
LAM.AX balance_sheet (annual, 2023-12-31) — Available For Sale Securities: 175118.00
LAM.AX income_statement (annual, 2023-12-31) — Basic Average Shares: 228818520.00
LAM.AX income_statement (annual, 2023-12-31) — Basic EPS: -0.02
LAM.AX cash_flow (annual, 2023-12-31) — Beginning Cash Position: 5127213.00
LAM.AX cash_flow (annual, 2023-12-31) — Capital Expenditure: -7094114.00
LAM.AX balance_sheet (annual, 2023-12-31) — Capital Stock: 184473906.00
LAM.AX balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 9101305.00
LAM.AX balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 9808844.00
LAM.AX balance_sheet (annual, 2023-12-31) — Cash Financial: 9101305.00
LAM.AX cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 13631296.00
LAM.AX cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -7130054.00
LAM.AX cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -2698642.00
LAM.AX cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: -104843.00
LAM.AX cash_flow (annual, 2023-12-31) — Change In Receivables: 79872.00
LAM.AX cash_flow (annual, 2023-12-31) — Change In Working Capital: -24971.00
LAM.AX cash_flow (annual, 2023-12-31) — Changes In Account Receivables: 79872.00
LAM.AX cash_flow (annual, 2023-12-31) — Changes In Cash: 3802600.00
LAM.AX balance_sheet (annual, 2023-12-31) — Common Stock: 184473906.00
LAM.AX balance_sheet (annual, 2023-12-31) — Common Stock Equity: 96642644.00
LAM.AX cash_flow (annual, 2023-12-31) — Common Stock Issuance: 10686000.00
LAM.AX balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 288511.00
LAM.AX balance_sheet (annual, 2023-12-31) — Current Assets: 10220872.00
LAM.AX balance_sheet (annual, 2023-12-31) — Current Debt: 4238145.00
LAM.AX balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 4238145.00
LAM.AX balance_sheet (annual, 2023-12-31) — Current Liabilities: 9292894.00
LAM.AX cash_flow (annual, 2023-12-31) — Deferred Income Tax: -263307.00
LAM.AX cash_flow (annual, 2023-12-31) — Deferred Tax: -263307.00
LAM.AX cash_flow (annual, 2023-12-31) — Depreciation: 132544.00
LAM.AX cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 132544.00
LAM.AX income_statement (annual, 2023-12-31) — Depreciation Amortization Depletion Income Statement: 132544.00
LAM.AX cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 132544.00
LAM.AX income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 132544.00
LAM.AX income_statement (annual, 2023-12-31) — Depreciation Income Statement: 132544.00
LAM.AX income_statement (annual, 2023-12-31) — Diluted Average Shares: 228818520.00
LAM.AX income_statement (annual, 2023-12-31) — Diluted EPS: -0.02
LAM.AX income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -4679440.00
LAM.AX income_statement (annual, 2023-12-31) — EBIT: -4125333.00
LAM.AX income_statement (annual, 2023-12-31) — EBITDA: -3992789.00
LAM.AX cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 171492.00
LAM.AX cash_flow (annual, 2023-12-31) — End Cash Position: 9101305.00
LAM.AX cash_flow (annual, 2023-12-31) — Financing Cash Flow: 13631296.00
LAM.AX cash_flow (annual, 2023-12-31) — Free Cash Flow: -9792756.00
LAM.AX cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: 280948.00
LAM.AX income_statement (annual, 2023-12-31) — Gain On Sale Of Security: -219997.00
LAM.AX balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: 1486531.00
LAM.AX income_statement (annual, 2023-12-31) — General And Administrative Expense: 2618134.00
LAM.AX balance_sheet (annual, 2023-12-31) — Gross PPE: 102068523.00
LAM.AX income_statement (annual, 2023-12-31) — Interest Expense: 817414.00
LAM.AX income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 817414.00
LAM.AX balance_sheet (annual, 2023-12-31) — Invested Capital: 100971274.00
LAM.AX cash_flow (annual, 2023-12-31) — Investing Cash Flow: -7130054.00
LAM.AX balance_sheet (annual, 2023-12-31) — Investmentin Financial Assets: 175118.00
LAM.AX balance_sheet (annual, 2023-12-31) — Investments And Advances: 175118.00
LAM.AX cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 10686000.00
LAM.AX cash_flow (annual, 2023-12-31) — Issuance Of Debt: 0.00
LAM.AX balance_sheet (annual, 2023-12-31) — Long Term Debt: 90485.00
LAM.AX balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 90485.00
LAM.AX cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 0.00
LAM.AX cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -1502542.00
LAM.AX balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 635422.00
LAM.AX cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 10686000.00
LAM.AX cash_flow (annual, 2023-12-31) — Net Foreign Currency Exchange Gain Loss: -72630.00
LAM.AX income_statement (annual, 2023-12-31) — Net Income: -4679440.00
LAM.AX income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -4679440.00
LAM.AX income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -4679440.00
LAM.AX income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -4679440.00
LAM.AX income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -4679440.00
LAM.AX cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -4679440.00
LAM.AX income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -4679440.00
LAM.AX income_statement (annual, 2023-12-31) — Net Interest Income: -817414.00
LAM.AX cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: -35940.00
LAM.AX cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -1502542.00